Allergan (NYSE: AGN) today confirmed that it’s in the running to acquire Shire (NSDQ:SHPGY), which rejected a $63 billion offer from Takeda Pharmaceutical (TYO:4502). Dublin-based Allergan, which is in the process of slashing 1,400 jobs from its payroll and exploring “strategic actions,” said there’s no guarantee it will make an offer for Shire. Get the full story at our sister […]
Spire Corp.
Spire Biomedical Awarded Grant for Dental Arch Wire Coatings
NIH awards Spire a nine-month SBIR grant worth over $100,000
BEDFORD, Mass.–(BUSINESS WIRE)–Spire Biomedical, a wholly-owned subsidiary of Spire Corporation (Nasdaq: SPIR), announced today that the National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR), has awarded Spire a nine-month Small Business Innovation Research (SBIR) Phase I Grant for $114,173, to develop coatings for dental arch wires used in orthodontics. The purpose of the coatings is to reduce sliding resistance between the arch wire and bracket, lowering the force required to straighten teeth, reducing treatment times, and resulting in more predictable outcomes for the orthodontist.
Spire sues Creganna-Tactx Medical unit over contract breach
Spire Corp.’s (NSDQ:SPIR) medical device unit sued Creganna-Tactx Medical subsidiary Catheter and Disposable Technology Inc. over an alleged breach of contract related to the manufacture of hemodialysis catheters.
The unit, Spire Biomedical Inc., yesterday filed a suit in U.S. District Court in Massachusetts alleging that CDT failed to assemble the catheters in accordance with its designs.
Spire closes hemodialysis catheter business sale to C.R. Bard
Spire Corp. (NSDQ:SPIR) closed the sale of its hemodialysis catheter business to a division of C.R. Bard (NYSE:BCR) Dec. 16, after postponing the merger several times and agreeing to accept $2.5 million less than the original offer.
In September 2009, Spire agreed to sell the seven-year-old operation to the Salt Lake City-based device maker’s Bard Access Systems division for $15 million, so it could focus on its core solar energy business.